INVO Fertility, Inc. IVF
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 16.73% | 23.09% | -75.76% | 22.60% | 1.48% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.73% | 23.09% | -75.76% | 22.60% | 1.48% |
| Cost of Revenue | 29.19% | 23.21% | -71.39% | 14.08% | 26.93% |
| Gross Profit | -0.96% | 22.88% | -81.32% | 41.51% | -21.01% |
| SG&A Expenses | -13.05% | 39.74% | -70.30% | 40.51% | -17.17% |
| Depreciation & Amortization | -14.20% | -39.15% | -85.17% | -40.69% | -26.31% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.25% | 27.13% | -72.75% | 24.11% | -7.57% |
| Operating Income | 19.02% | -32.64% | 68.35% | -25.77% | 16.30% |
| Income Before Tax | 161.23% | -271.20% | -41.44% | -65.14% | 31.27% |
| Income Tax Expenses | -- | -- | -556.77% | -- | -- |
| Earnings from Continuing Operations | 157.59% | -271.20% | -37.16% | -62.18% | 31.27% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 124.56% | 68.17% | -37.16% | -62.18% | -61.19% |
| EBIT | 19.02% | -32.64% | 68.35% | -25.77% | 16.30% |
| EBITDA | 19.60% | -50.07% | 69.85% | -40.08% | 14.92% |
| EPS Basic | 100.03% | 99.78% | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | 100.02% | 99.78% | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 22,244.83% | 14,019.83% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |